These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30099926)

  • 1. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
    Tinhofer I; Staudte S
    Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.
    Suh YS; Joung JY; Kim SH; Seo HK; Chung J; Lee KH
    Biomed Res Int; 2017; 2017():7206307. PubMed ID: 29230413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
    Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
    J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using CTCs for pharmacogenomic analysis.
    Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A
    Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
    Gao Y; Zhu Y; Yuan Z
    Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
    Alberter B; Klein CA; Polzer B
    Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
    Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients.
    Salvianti F; Pinzani P
    Expert Rev Mol Diagn; 2017 Nov; 17(11):975-981. PubMed ID: 28931314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Hou S; Li Q; Hsieh C; Song M; Liao X; Rochefort MM; Wainberg ZA; Graeber TG; Tseng HR; Tomlinson JS
    J Mol Diagn; 2016 Sep; 18(5):688-696. PubMed ID: 27375074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.